New Key Statistics Module, Z-Score and F-Score
OTCPK:MBGPF Key Ratios
Market Cap $ M | 51.69 |
Enterprise Value $ M | 21.23 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.58 |
Price/Sales | 78.52 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.09 |
Beneish M-Score | 17.67 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -8.28 |
EV-to-EBITDA | -8.78 |
PEG | -- |
Shares Outstanding M | 46.69 |
Net Margin (%) | -461.64 |
Operating Margin % | -595.33 |
Pre-tax Margin (%) | -554.41 |
Quick Ratio | 12.32 |
Current Ratio | 12.49 |
ROA % (ttm) | -3.33 |
ROE % (ttm) | -3.46 |
ROIC % (ttm) | -4.20 |
Dividend Yield % | -- |
Altman Z-Score | 10.53 |
MBGPF Number of Guru Trades
MBGPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MBGPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MBGPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Moberg Pharma AB Insider Transactions
No Available Data
News about OTCPK:MBGPF
Total 0- 1